Reduction of both APOE and TREM2 with ASOs lowered the expression of HLA genes, which indicates that ASOs targeting AD risk genes can diminish microglia activation even in the presence of amyloid-β pathology. The gene discussed is TREM2; the disease is Alzheimer disease.